Change in Neurocognitive Function in Patients Who Receive CAR-T Cell Therapies: A Steep Hill to Climb

Immunotherapy with chimeric antigen receptor T (CAR-T) cell therapies has brought substantial improvement in clinical outcomes in patients with relapsed/refractory B cell neoplasms. However, complications such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndr...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Pharmaceuticals
المؤلفون الرئيسيون: Evlampia Strongyli, Paschalis Evangelidis, Ioanna Sakellari, Maria Gavriilaki, Eleni Gavriilaki
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2024-05-01
الموضوعات:
apraxia
cognition
CAR-T
ICANS
lymphoma
memory
الوصول للمادة أونلاين:https://www.mdpi.com/1424-8247/17/5/591

الانترنت

https://www.mdpi.com/1424-8247/17/5/591

مواد مشابهة